- Report
- January 2026
- 181 Pages
Global
From €3177EUR$3,545USD£2,770GBP
€3530EUR$3,939USD£3,077GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,508GBP
- Report
- January 2026
- 281 Pages
Global
From €2241EUR$2,500USD£1,953GBP
- Report
- February 2026
- 160 Pages
Global
From €2975EUR$3,320USD£2,594GBP
€3719EUR$4,150USD£3,242GBP
- Report
- October 2025
- 160 Pages
Global
From €3009EUR$3,358USD£2,623GBP
€3540EUR$3,950USD£3,086GBP
- Report
- July 2025
- 150 Pages
Global
From €5332EUR$5,950USD£4,649GBP
- Report
- January 2026
- 181 Pages
Global
From €3177EUR$3,545USD£2,770GBP
€3530EUR$3,939USD£3,077GBP
- Report
- January 2026
- 199 Pages
Global
From €3177EUR$3,545USD£2,770GBP
€3530EUR$3,939USD£3,077GBP
- Report
- November 2025
- 188 Pages
Global
From €3177EUR$3,545USD£2,770GBP
€3530EUR$3,939USD£3,077GBP
- Report
- August 2025
- 182 Pages
Global
From €3177EUR$3,545USD£2,770GBP
€3530EUR$3,939USD£3,077GBP
- Report
- August 2025
- 186 Pages
Global
From €3177EUR$3,545USD£2,770GBP
€3530EUR$3,939USD£3,077GBP
- Report
- August 2025
- 196 Pages
Global
From €3177EUR$3,545USD£2,770GBP
€3530EUR$3,939USD£3,077GBP
- Report
- August 2025
- 182 Pages
Global
From €3177EUR$3,545USD£2,770GBP
€3530EUR$3,939USD£3,077GBP
- Report
- August 2025
- 199 Pages
Global
From €3177EUR$3,545USD£2,770GBP
€3530EUR$3,939USD£3,077GBP
- Report
- August 2025
- 186 Pages
Global
From €3177EUR$3,545USD£2,770GBP
€3530EUR$3,939USD£3,077GBP
- Report
- April 2026
- 270 Pages
Global
From €5243EUR$5,850USD£4,570GBP
- Report
- April 2026
- 340 Pages
Global
From €5243EUR$5,850USD£4,570GBP
- Report
- January 2026
- 180 Pages
Global
From €4033EUR$4,500USD£3,516GBP
- Report
- January 2026
- 130 Pages
Global
From €4257EUR$4,750USD£3,711GBP
- Report
- May 2025
- 150 Pages
Global
From €4347EUR$4,850USD£3,789GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more